Cargando…

Changes of High Sensitivity C-Reactive Protein During Clopidogrel Therapy in Patients Undergoing Percutaneous Coronary Intervention

BACKGROUND: The crucial role of inflammation in the development and progression of atherosclerosis has been previously described. However, there is insufficient data available to demonstrate the changes in high sensitivity C-reactive protein (hs-CRP) during clopidogrel therapy. OBJECTIVES: In the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hajsadeghi, Shokoufeh, Chitsazan, Mandana, Chitsazan, Mitra, Salehi, Negar, Amin, Ahmad, Maleki, Majid, Babaali, Nima, Abdi, Seifollah, Mohsenian, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749892/ https://www.ncbi.nlm.nih.gov/pubmed/26889454 http://dx.doi.org/10.5812/cardiovascmed.28997

Ejemplares similares

Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2016)

Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2015)

Pulsatility Index in Aortic Coarctation: A Possible Way to Evaluate Factors Affecting Stenting Outcome
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2012)

Predictors of Prolonged Mechanical Ventilation after Open Heart Surgery
por: Totonchi, Ziae, et al.
Publicado: (2014)

Doppler echocardiographic indices in aortic coarctation: a comparison of profiles before and after stenting
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2012)

Heart failure with preserved ejection fraction in coronavirus disease 2019 patients: the promising role of diuretic therapy in critically ill patients
por: Chitsazan, Mitra, et al.
Publicado: (2021)

Measurement of pulmonary arterial elastance in patients with systolic heart failure using Doppler echocardiography
por: Taghavi, Sepideh, et al.
Publicado: (2016)

Anesthetic Management in a Patient With Type A Aortic Dissection and Superior Vena Cava Syndrome
por: Totonchi, Ziae, et al.
Publicado: (2015)

Periprocedural Hemoglobin Changes and Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention
por: Alizadeh, Keivan, et al.
Publicado: (2013)

Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low‐triiodothyronine syndrome: a randomized, double‐blind, placebo‐controlled study
por: Amin, Ahmad, et al.
Publicado: (2015)

Immediate Results of Percutaneous Trans-Luminal Mitral Commissurotomy in Pregnant Women with Severe Mitral Stenosis
por: Abdi, Seyfollah, et al.
Publicado: (2012)

Cardiovascular Disease in the COVID-19 Era: Myocardial Injury and Thrombosis
por: Amin, Ahmad, et al.
Publicado: (2022)

Association of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention
por: Namazi, Soha, et al.
Publicado: (2020)

Safety and Efficacy of Caproamin Fides and Tranexamic Acid Versus Placebo in Patients Undergoing Coronary Artery Revascularization
por: Alizadeh Ghavidel, Alireza, et al.
Publicado: (2014)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
por: YANG, Bin, et al.
Publicado: (2018)

On admission serum sodium and uric acid levels predict 30 day rehospitalization or death in patients with acute decompensated heart failure
por: Amin, Ahmad, et al.
Publicado: (2017)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Norgard, Nicholas B, et al.
Publicado: (2009)

High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel
por: Geisler, Tobias, et al.
Publicado: (2015)

Thrombelastography Compared with Multiple Impedance Aggregometry to Assess High On-Clopidogrel Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Gjermeni, Diona, et al.
Publicado: (2022)

Relationship between Serum Uric Acid Levels and the Severity of Pulmonary Hypertension
por: Seyyedi, Seyyed Reza, et al.
Publicado: (2017)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

The Impact of Clopidogrel Resistance on Clinical Outcome of Iranian Patients Undergoing Percutaneous Coronary Intervention
por: Haji Aghajani, Mohammad, et al.
Publicado: (2018)

The Relationship between Electrocardiographic Changes and Prognostic Factors in Severely Symptomatic Pulmonary Hypertension
por: Seyyedi, Seyed Reza, et al.
Publicado: (2019)

Relationship between Pre-Procedural Serum Lipid Profile and Post-Procedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Maadani, Mohsen, et al.
Publicado: (2013)

Pain Location and Intensity During the First Week Following Coronary Artery Bypass Graft Surgery
por: Totonchi, Ziae, et al.
Publicado: (2013)

Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Jianan, et al.
Publicado: (2021)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019)

Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Zhang, Xiaoyan, et al.
Publicado: (2019)

Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention
por: Chen, Lida, et al.
Publicado: (2022)

Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention
por: Jeong, Young-Hoon, et al.
Publicado: (2012)

Author's Reply
por: Hajsadeghi, Shokoufeh
Publicado: (2016)

Author`s Reply
por: Hajsadeghi, Shokoufeh
Publicado: (2016)

Comparison of prasugrel and clopidogrel reloading on high platelet reactivity in clopidogrel-loaded patients undergoing percutaneous coronary intervention (PRAISE-HPR): a study protocol for a prospective randomized controlled clinical trial
por: Lee, Dong-Hyun, et al.
Publicado: (2013)

In-hospital and six-month outcomes of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction
por: Noohi, Fereydoon, et al.
Publicado: (2016)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Correction: Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
Publicado: (2019)

Optimization of DRASTIC method by artificial neural network, nitrate vulnerability index, and composite DRASTIC models to assess groundwater vulnerability for unconfined aquifer of Shiraz Plain, Iran
por: Baghapour, Mohammad Ali, et al.
Publicado: (2016)

Removing an Entrapped Pigtail Catheter by Re-enforcing a Traditional Method
por: Serati, Alireza, et al.
Publicado: (2019)

Intramural Esophageal Dissection: A Rare Cause of Acute Chest Pain after Percutaneous Coronary Intervention
por: Abdi, Seifollah, et al.
Publicado: (2019)

Evaluation of the Clinical and Procedural Predictive Factors of no-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention
por: Abdi, Seifollah, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gb5d4crker8iqlg9tlgvmnd9pr